Editorial: PD-1, a new target for sepsis treatment: better late than never.
Goyert
Sanna M
SM
Silver
Jack
J
D000906:Antibodies / Q000627:therapeutic use; D015703:Antigens, CD / Q000276:immunology; D017209:Apoptosis; D051017:Apoptosis Regulatory Proteins / Q000037:antagonists & inhibitors* / Q000276:immunology; D016503:Drug Delivery Systems / Q000379:methods; D054884:Host-Pathogen Interactions; D006801:Humans; D007165:Immunosuppression Therapy; D061026:Programmed Cell Death 1 Receptor; D018805:Sepsis / Q000628:therapy*; D012772:Shock, Septic / Q000628:therapy
D000906:Antibodies; D015703:Antigens, CD; D051017:Apoptosis Regulatory Proteins; C105992:PDCD1 protein, human; D061026:Programmed Cell Death 1 Receptor